Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS3 | P17931 | 3/20 | 0.69 |
| ▸ | LGALS8 | O00214 | 2/20 | 0.69 |
| ▸ | LGALS4 | P56470 | 2/20 | 0.69 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.65 |
| ▸ | CD69 | Q07108 | 1/20 | 0.51 |
| ▸ | IFNG | P01579 | 1/20 | 0.49 |
| ▸ | FGF1 | P05230 | 1/20 | 0.49 |
| ▸ | FGF2 | P09038 | 1/20 | 0.49 |
| ▸ | BMP2 | P12643 | 1/20 | 0.49 |
| ▸ | VEGFA | P15692 | 1/20 | 0.49 |
| ▸ | SFRP1 | Q8N474 | 1/20 | 0.49 |
| ▸ | CHIA | Q9BZP6 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | THRB | P10828 | 1/20 | 0.47 |
| ▸ | IGF2R | P11717 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | SIGLEC7 | Q9Y286 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17832654 | 1.00 | LGALS3 (0.69) | LGALS3LGALS8LGALS4MAPK1CD69 | |
| SCHEMBL17822271 | 1.00 | LGALS3 (0.69) | LGALS3LGALS8LGALS4MAPK1CD69 | |
| SCHEMBL17832730 | 0.94 | LGALS8 (0.61) | LGALS3LGALS8LGALS4MAPK1CD69 | |
| SCHEMBL19404728 | 0.94 | LGALS3 (0.64) | LGALS3LGALS8LGALS4MAPK1CD69 | |
| SCHEMBL19614256 | 0.94 | LGALS8 (0.61) | LGALS3LGALS8LGALS4MAPK1CD69 | |
| SCHEMBL17822272 | 0.93 | LGALS8 (0.60) | LGALS3LGALS8LGALS4MAPK1CD69 | |
| SCHEMBL19614147 | 0.93 | LGALS8 (0.60) | LGALS3LGALS8LGALS4MAPK1CD69 | |
| SCHEMBL17832655 | 0.93 | LGALS8 (0.60) | LGALS3LGALS8LGALS4MAPK1CD69 | |
| SCHEMBL19614152 | 0.93 | LGALS8 (0.60) | LGALS3LGALS8LGALS4MAPK1CD69 | |
| SCHEMBL18608298 | 0.92 | LGALS8 (0.67) | LGALS3LGALS8LGALS4MAPK1CD69 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10188718-B2 | Vaccines against Streptococcus pneumoniae serotype 4 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2019-01-29 | — | — | US | disclosed |
| EP-3230297-B1 | VACCINES AGAINST STREPTOCOCCUS PNEUMONIAE SEROTYPE 4 | MAX PLANCK GESELLSCHAFT (DE) | 2018-10-17 | — | — | EP | disclosed |
| US-20170333545-A1 | VACCINES AGAINST STREPTOCOCCUS PNEUMONIAE SEROTYPE 4 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2017-11-23 | — | — | US | disclosed |
| EP-3230297-A1 | VACCINES AGAINST STREPTOCOCCUS PNEUMONIAE SEROTYPE 4 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2017-10-18 | — | — | EP | disclosed |
| WO-2016091399-A1 | VACCINES AGAINST STREPTOCOCCUS PNEUMONIAE SEROTYPE 4 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2016-06-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170333545-A1 | VACCINES AGAINST STREPTOCOCCUS PNEUMONIAE SEROTYPE 4 | NEU4, PA2G4, STT3B | LGALS3 82/4885LGALS8 169/4885LGALS4 12/4885 |
| US-10188718-B2 | Vaccines against Streptococcus pneumoniae serotype 4 | NEU4, PA2G4, STT3B | LGALS3 82/4885LGALS8 169/4885LGALS4 12/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.